HTG Molecular Diagnostics, Inc. Proceeds from Common Stock Issued
HTG Molecular Diagnostics, Inc. reported Proceeds from Common Stock Issued of $2.40 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-05-13
- HTG Molecular Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2020-03-31 was $2.40M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2018-06-30 was $20.20M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2018-03-31 was $20.20M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance of common stock for the quarter ending 2017-09-30 was $2.00M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month |
|---|---|---|---|
| 2020-03-31 | $2.40M 10-Q · filed 2020-05-13 | ||
| 2018-06-30 | $20.20M 10-Q · filed 2019-11-12 | $20.20M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $20.20M 10-K · filed 2020-03-25 | ||
| 2017-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $16.70M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $14.70M 10-Q · filed 2017-08-08 |